Cite
Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma.
MLA
Zhang, Fan, et al. “Combination of Canstatin and Arsenic Trioxide Suppresses the Development of Hepatocellular Carcinoma.” Drug Development Research, vol. 82, no. 3, May 2021, pp. 430–39. EBSCOhost, https://doi.org/10.1002/ddr.21766.
APA
Zhang, F., Duan, J., Song, H., Yang, L., Zhou, M., & Wang, X. (2021). Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma. Drug Development Research, 82(3), 430–439. https://doi.org/10.1002/ddr.21766
Chicago
Zhang, Fan, Jingjing Duan, Hailin Song, Li Yang, Ming Zhou, and Xuewen Wang. 2021. “Combination of Canstatin and Arsenic Trioxide Suppresses the Development of Hepatocellular Carcinoma.” Drug Development Research 82 (3): 430–39. doi:10.1002/ddr.21766.